Xing Ma

668 total citations
23 papers, 414 citations indexed

About

Xing Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xing Ma has authored 23 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Xing Ma's work include Pluripotent Stem Cells Research (4 papers), Hedgehog Signaling Pathway Studies (3 papers) and Ferroptosis and cancer prognosis (3 papers). Xing Ma is often cited by papers focused on Pluripotent Stem Cells Research (4 papers), Hedgehog Signaling Pathway Studies (3 papers) and Ferroptosis and cancer prognosis (3 papers). Xing Ma collaborates with scholars based in China, United States and Australia. Xing Ma's co-authors include Juhua Zhuang, Saifei He, Wei Xia, Yanan Song, Miao Zhang, Ting Xie, Xiaoqing Song, Ying Ye, Jiening Wang and Zhihao Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Development and The Science of The Total Environment.

In The Last Decade

Xing Ma

23 papers receiving 411 citations

Peers

Xing Ma
Samuel R. Meier United States
Hanbin Dan United States
Olga Kelemen Germany
Daniel Biggs United Kingdom
Hua Luo China
Ellen Youngsoo Rim United States
Samuel R. Meier United States
Xing Ma
Citations per year, relative to Xing Ma Xing Ma (= 1×) peers Samuel R. Meier

Countries citing papers authored by Xing Ma

Since Specialization
Citations

This map shows the geographic impact of Xing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Ma more than expected).

Fields of papers citing papers by Xing Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Ma. The network helps show where Xing Ma may publish in the future.

Co-authorship network of co-authors of Xing Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Ma. A scholar is included among the top collaborators of Xing Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Ma. Xing Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Xing, et al.. (2024). Silencing HEATR1 Rescues Cisplatin Resistance of Non-small Cell Lung Cancer by Inducing Ferroptosis via the p53/SAT1/ALOX15 Axis. Current Cancer Drug Targets. 25(4). 345–356. 5 indexed citations
2.
Ma, Xing, Wenxiang He, Mallavarapu Megharaj, et al.. (2024). Extracellular enzymes as reliable indicators of long-term antimony contamination. The Science of The Total Environment. 958. 178070–178070. 1 indexed citations
3.
Fan, Miaochun, Jiajia Li, Xiaobo Luan, et al.. (2023). Biogeographical patterns of rhizosphere microbial communities in Robinia pseudoacacia forests along a north–south transect in the Loess Plateau. Geoderma. 435. 116516–116516. 19 indexed citations
4.
Wang, Yingmei, Xing Ma, Xin Liu, et al.. (2022). Modification of alternative splicing in bovine somatic cell nuclear transfer embryos using engineered CRISPR-Cas13d. Science China Life Sciences. 65(11). 2257–2268. 5 indexed citations
5.
Ma, Xing, et al.. (2022). Respecting catalytic efficiency of soil arylsulfatase as soil Sb contamination bio-indicator by enzyme kinetic strategy. Environmental Science and Pollution Research. 30(7). 17644–17656. 4 indexed citations
6.
Ma, Xing, Xiaowei Yu, Xin Chen, et al.. (2021). Genistein interferes with antitumor effects of cisplatin in an ovariectomized breast cancer xenograft tumor model. Toxicology Letters. 355. 106–115. 11 indexed citations
7.
Wang, Yingmei, Jing Han, Xing Ma, et al.. (2021). Asymmetric expression of maternal mRNA governs first cell‐fate decision. The FASEB Journal. 35(11). e22006–e22006. 3 indexed citations
8.
He, Saifei, Miao Zhang, Ying Ye, et al.. (2021). GINS2 affects cell proliferation, apoptosis, migration and invasion in thyroid cancer via regulating MAPK signaling pathway. Molecular Medicine Reports. 23(4). 6 indexed citations
9.
Li, Yan, Xing Ma, Jun Li, et al.. (2021). LncRNA gas5 regulates granulosa cell apoptosis and viability following radiation by X-ray through sponging miR-205-5p and Wnt/β-catenin signaling pathway ingranulosa cell tumor of ovary. Tropical Journal of Pharmaceutical Research. 19(12). 2491–2498. 2 indexed citations
10.
Zhang, Miao, Saifei He, Xing Ma, et al.. (2020). GINS2 affects cell viability, cell apoptosis, and cell cycle progression of pancreatic cancer cells via MAPK/ERK pathway. Journal of Cancer. 11(16). 4662–4670. 17 indexed citations
11.
Ma, Xing, Jiening Wang, Juhua Zhuang, et al.. (2020). P4HB modulates epithelial‑mesenchymal transition and the β‑catenin/Snail pathway influencing chemoresistance in liver cancer cells. Oncology Letters. 20(1). 257–265. 27 indexed citations
12.
Song, Yanan, Saifei He, Xing Ma, et al.. (2020). RBMX contributes to hepatocellular carcinoma progression and sorafenib resistance by specifically binding and stabilizing BLACAT1.. PubMed. 10(11). 3644–3665. 36 indexed citations
13.
Ma, Xing, Hua Li, Kathryn Hall, et al.. (2019). Defining the expression of piRNA and transposable elements inDrosophilaovarian germline stem cells and somatic support cells. Life Science Alliance. 2(5). e201800211–e201800211. 14 indexed citations
14.
Zhuang, Juhua, Yanan Song, Ying Ye, et al.. (2019). PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer. Journal of Translational Medicine. 17(1). 343–343. 45 indexed citations
15.
He, Saifei, Xing Ma, Ying Ye, et al.. (2019). <p>HEATR1 modulates cell survival in non-small cell lung cancer via activation of the p53/PUMA signaling pathway</p>. OncoTargets and Therapy. Volume 12. 4001–4011. 14 indexed citations
16.
Li, Meng, et al.. (2017). The conformation change and tumor suppressor role of Merlin are both independent of Serine 518 phosphorylation. Biochemical and Biophysical Research Communications. 493(1). 46–51. 7 indexed citations
17.
Ma, Xing, Xiujuan Zhu, Yingying Han, et al.. (2017). Aubergine Controls Germline Stem Cell Self-Renewal and Progeny Differentiation via Distinct Mechanisms. Developmental Cell. 41(2). 157–169.e5. 47 indexed citations
18.
Ma, Xing, Yingying Han, Xiaoqing Song, et al.. (2016). DNA damage-induced Lok/CHK2 activation compromises germline stem cell self-renewal and lineage differentiation. Development. 143(23). 4312–4323. 31 indexed citations
19.
Wang, Su, Xiaoqing Song, Xing Ma, et al.. (2015). Wnt signaling-mediated redox regulation maintains the germ line stem cell differentiation niche. eLife. 4. e08174–e08174. 57 indexed citations
20.
Ma, Xing & Ting Xie. (2011). Stem Cells: Keeping BMP Signaling Local. Current Biology. 21(19). R809–R811. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026